Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oral Alpan

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Blood Cells, Molecules & Diseases|November 15, 2016
Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher DiseaseRenuka Pudi Limgala, Chandni Jani, Chidima Ioanou, et al.
Allergy|September 10, 2020
Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapyOral Alpan, Janice A Layhadi, Søren Ulrik Sønder, et al.
The Journal of Allergy and Clinical Immunology. Global|December 24, 2025
Dupilumab opens a therapeutic window in food protein-induced enterocolitis syndrome by unlicensing dendritic cellsMatthew Plassmeyer, Naomi Enav, Michael Girgis, et al.
Journal of Hepatology|July 10, 2020
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19Alexander Kroemer, Khalid Khan, Matthew Plassmeyer, et al.
Journal of Immunological Methods|January 24, 2025
Basophil activation test; User's manualSoren Ulrik Sonder, Matthew Plassmeyer, Nikhila Schroeder, et al.
Frontiers in Immunology|March 10, 2022
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed TherapiesThomas A Premeaux, Stephen T Yeung, Zaheer Bukhari, et al.
Cytometry. Part B, Clinical Cytometry|May 12, 2017
Improved panels for clinical immune phenotyping: Utilization of the violet laserMark Ryherd, Matthew Plassmeyer, Connor Alexander, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
Persistent immune alterations and comorbidities in splenectomized patients with Gaucher diseaseSøren Ulrik Sønder, Renuka Pudi Limgala, Margarita M Ivanova, et al.
Plos One|December 13, 2016
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher DiseaseRenuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, et al.
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Blood Cells, Molecules & Diseases|November 15, 2016
Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher DiseaseRenuka Pudi Limgala, Chandni Jani, Chidima Ioanou, et al.
Allergy|September 10, 2020
Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapyOral Alpan, Janice A Layhadi, Søren Ulrik Sønder, et al.
The Journal of Allergy and Clinical Immunology. Global|December 24, 2025
Dupilumab opens a therapeutic window in food protein-induced enterocolitis syndrome by unlicensing dendritic cellsMatthew Plassmeyer, Naomi Enav, Michael Girgis, et al.
Journal of Hepatology|July 10, 2020
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19Alexander Kroemer, Khalid Khan, Matthew Plassmeyer, et al.
Journal of Immunological Methods|January 24, 2025
Basophil activation test; User's manualSoren Ulrik Sonder, Matthew Plassmeyer, Nikhila Schroeder, et al.
Frontiers in Immunology|March 10, 2022
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed TherapiesThomas A Premeaux, Stephen T Yeung, Zaheer Bukhari, et al.
Cytometry. Part B, Clinical Cytometry|May 12, 2017
Improved panels for clinical immune phenotyping: Utilization of the violet laserMark Ryherd, Matthew Plassmeyer, Connor Alexander, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
Persistent immune alterations and comorbidities in splenectomized patients with Gaucher diseaseSøren Ulrik Sønder, Renuka Pudi Limgala, Margarita M Ivanova, et al.
Plos One|December 13, 2016
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher DiseaseRenuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, et al.
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.
Pageof 4